List of insiders holdings for Inozyme Pharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
2023-08-11 16:08:56 | 5,841,045 0 |
5,841,045 | Form 13D |
2 | Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd Director |
2024-02-12 21:06:26 | 4,494,851 0 |
4,494,851 | Form 13D |
3 | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
2024-02-20 19:11:01 | 4,280,308 0 |
4,280,308 | Form 13D |
4 | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
2024-02-14 14:10:03 | 3,681,174 0 |
3,681,174 | Form 13G |
5 | MAKOWER JOSHUA 10% Owner |
2020-07-28 18:29:09 | 0 2,437,689 |
2,437,689 | Form 4 |
6 | Sonsini Peter W. 10% Owner |
2020-07-28 18:30:55 | 0 2,437,689 |
2,437,689 | Form 4 |
7 | SANDELL SCOTT D 10% Owner |
2020-07-28 18:29:54 | 0 2,437,689 |
2,437,689 | Form 4 |
8 | Makhzoumi Mohamad 10% Owner |
2020-07-28 18:28:20 | 0 2,437,689 |
2,437,689 | Form 4 |
9 | Florence Anthony A. Jr. 10% Owner |
2020-07-28 18:27:42 | 0 2,437,689 |
2,437,689 | Form 4 |
10 | BASKETT FOREST 10% Owner |
2020-07-28 18:26:52 | 0 2,437,689 |
2,437,689 | Form 4 |
11 | Novo Holdings A/S 10% Owner |
2021-07-30 16:31:00 | 1,167,706 0 |
1,167,706 | Form 13D |
12 | ALEXION PHARMACEUTICALS INC. 10% Owner |
2020-07-28 18:11:09 | 1,109,910 0 |
1,109,910 | Form 4 |
13 | Sanofi 10% Owner |
2020-07-29 06:06:37 | 0 520,125 |
520,125 | Form 4 |
14 | Braddock Demetrios 10% Owner |
2020-07-23 21:19:08 | 404,142 0 |
404,142 | Form 3 |
15 | Schlessinger Joseph 10% Owner |
2020-07-28 18:13:16 | 286,479 0 |
286,479 | Form 4 |
16 | Bjarke Henric Bjorn SVP, COO |
2022-12-19 08:30:09 | 105,441 0 |
105,441 | Form 4 |
17 | Wenkert Deborah SVP, CMO |
2021-02-04 17:11:58 | 100,000 0 |
100,000 | Form 4 |
18 | Treco Douglas A CEO & Chairman |
2025-04-03 16:27:09 | 91,046 0 |
91,046 | Form 4 |
19 | Harris Erik Director |
2024-10-07 16:37:36 | 56,000 0 |
56,000 | Form 4 |
20 | Jungles Steven J SVP, CTO |
2021-03-17 17:57:38 | 42,000 0 |
42,000 | Form 4 |
21 | Huertas Pedro SVP, CMO |
2021-01-14 16:17:14 | 36,074 0 |
36,074 | Form 4 |
22 | Subramanian Sanjay SVP, CFO & Head of BD |
2025-04-02 16:27:45 | 32,888 0 |
32,888 | Form 4 |
23 | Edwards Martin Director |
2024-06-20 16:07:25 | 28,000 0 |
28,000 | Form 4 |
24 | Bolte Axel Director |
2024-06-20 16:09:38 | 28,000 0 |
28,000 | Form 4 |
25 | Bhagat Sarah M Director |
2024-06-20 16:11:05 | 28,000 0 |
28,000 | Form 4 |
26 | Sullivan Lynne Marie Director |
2024-06-20 16:12:40 | 28,000 0 |
28,000 | Form 4 |
27 | DIAZ REINALDO M Director |
2024-06-20 16:14:28 | 28,000 0 |
28,000 | Form 4 |
28 | Hopfner Robert Lorne Director |
2024-06-20 16:15:36 | 28,000 0 |
28,000 | Form 4 |
29 | Mathers Edward T Director |
2024-06-20 16:30:03 | 28,000 0 |
28,000 | Form 4 |
30 | DiPalma Stephen J. Interim CFO |
2021-05-18 16:18:59 | 15,000 0 |
15,000 | Form 4 |
31 | Basso Stephen SVP Finance (PFO) |
2021-03-25 16:05:22 | 13,000 0 |
13,000 | Form 4 |
32 | Inozyme Pharma Inc. Director |
2021-06-24 16:10:00 | 9,367 0 |
9,367 | Form 4 |
33 | Winton Matthew COO |
2025-04-02 16:29:22 | 7,388 0 |
7,388 | Form 4 |
34 | New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC 10% Owner |
2024-02-14 18:08:47 | 0 0 |
0 | Form 13G |
35 | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
2021-11-15 16:35:14 | 0 0 |
0 | Form 13G |